← Browse by Condition

Medical Condition

sarcopenia

Total Trials

21

Recruiting Now

21

Trial Phases

Phase 3, Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for sarcopenia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — sarcopenia Clinical Trials

How many clinical trials are currently recruiting for sarcopenia?

ClinicalMetric currently tracks 21 actively recruiting clinical trials for sarcopenia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 21. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for sarcopenia?

sarcopenia research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a sarcopenia clinical trial?

Eligibility criteria for sarcopenia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

1

Phase 3

1

Phase 4

1

Top Sponsors

Medical University of Graz 1 trial

Sengkang General Hospital 1 trial

University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) 1 trial

Zhejiang Provincial Tongde Hospital 1 trial

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1 trial

Recruiting Clinical Trials

Austrian Biobanking Study for Sarcopenia

Medical University of Graz

NCT06708741 Phase 3

Regime for Vitamin D Maintenance in Post-Operative Patients

Sengkang General Hospital

Sarcopenia in Acute Ischemic Stroke

University Clinical Hospital n...

Silkworm Pupa Powder Improves Dementia.

Zhejiang Provincial Tongde Hos...

Mechanism of TIPS to Improve Sarcopenia

Union Hospital, Tongji Medical...

Sarcopenia in Older Patients Hospitalized for Acute Heart Failure.

Fundacion para la Investigacio...

NCT06537115 Phase 4

Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia

Zhejiang Provincial People's H...

Muscle Aging Phenotypes in Childhood Cancer Survivors

St. Jude Children's Research H...

Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study

Turkey (Türkiye)

Kanuni Sultan Suleyman Trainin...

Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)

Relevance of Sarcopenia in Advanced Liver Disease

Linkoeping University

MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients

Health Discovery Labs

Longitudinal Body Composition Assessment in Breast Cancer Patients

Taipei Tzu Chi Hospital, Buddh...

High-definition Surface Electromyography Markers for the Diagnosis of Sarcopenia

Assistance Publique - Hôpitaux...

NCT07597850 Phase 2

TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status

Tri-Service General Hospital (...

Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment

Ohio University

Establishment and Application of Digital Diagnosis and Treatment System for Sarcopenia

Peking Union Medical College H...

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Wake Forest University Health ...

HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke

Turkey (Türkiye)

Fenerbahce University

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

Instituto Nacional de Cancerol...

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Cliniques universitaires Saint...

Related Conditions

osteoporosis (2) metabolic diseases (2) aging (2) acute stroke (1) alzheimer disease ad (1) asthenia (1) mechanism (1) cirrhosis (1) acute heart failure ahf (1) heart failure (1) muscle weakness (1) low muscle mass (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology